Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

What Hedge Funds and Insiders Think About Piper Jaffray Companies (PJC)

Page 1 of 2

In the eyes of many investors, hedge funds are assumed to be useless, old financial vehicles of an era lost to time. Although there are over 8,000 hedge funds trading currently, this site aim at the masters of this club, about 525 funds. Analysts calculate that this group controls the majority of all hedge funds’ total assets, and by tracking their highest quality picks, we’ve uncovered a few investment strategies that have historically beaten the S&P 500. Our small-cap hedge fund strategy beat the S&P 500 index by 18 percentage points per annum for a decade in our back tests, and since we’ve began to sharing our picks with our subscribers at the end of August 2012, we have trumped the S&P 500 index by 33 percentage points in 11 months (see all of our picks from August).

Just as useful, optimistic insider trading activity is another way to analyze the world of equities. Just as you’d expect, there are many reasons for an insider to get rid of shares of his or her company, but just one, very obvious reason why they would behave bullishly. Several academic studies have demonstrated the useful potential of this strategy if “monkeys” know where to look (learn more here).

What’s more, let’s examine the recent info about Piper Jaffray Companies (NYSE:PJC).

Piper Jaffray Companies (NYSE:PJC)

What does the smart money think about Piper Jaffray Companies (NYSE:PJC)?

Heading into Q3, a total of 12 of the hedge funds we track held long positions in this stock, a change of 0% from one quarter earlier. With the smart money’s capital changing hands, there exists a select group of noteworthy hedge fund managers who were boosting their stakes significantly.

Out of the hedge funds we follow, Chuck Royce’s Royce & Associates had the most valuable position in Piper Jaffray Companies (NYSE:PJC), worth close to $13.7 million, comprising less than 0.1%% of its total 13F portfolio. The second largest stake is held by Parameter Capital Management, managed by Anil Stevens and Glenn Shapiro, which held a $7.4 million position; the fund has 1.4% of its 13F portfolio invested in the stock. Other peers with similar optimism include Cliff Asness’s AQR Capital Management, Jim Simons’s Renaissance Technologies and Gregory Fraser, Rudolph Kluiber, and Timothy Krochuk’s GRT Capital Partners.

Because Piper Jaffray Companies (NYSE:PJC) has witnessed bearish sentiment from the entirety of the hedge funds we track, it’s easy to see that there is a sect of fund managers who sold off their full holdings in Q1. At the top of the heap, David Costen Haley’s HBK Investments sold off the largest stake of the 450+ funds we watch, valued at close to $0.9 million in stock. John Overdeck and David Siegel’s fund, Two Sigma Advisors, also sold off its stock, about $0.2 million worth. These moves are intriguing to say the least, as total hedge fund interest stayed the same (this is a bearish signal in our experience).

What do corporate executives and insiders think about Piper Jaffray Companies (NYSE:PJC)?

Insider buying made by high-level executives is most useful when the primary stock in question has seen transactions within the past 180 days. Over the last 180-day time frame, Piper Jaffray Companies (NYSE:PJC) has experienced zero unique insiders purchasing, and zero insider sales (see the details of insider trades here).

We’ll check out the relationship between both of these indicators in other stocks similar to Piper Jaffray Companies (NYSE:PJC). These stocks are GFI Group Inc. (NYSE:GFIG), Medley Capital Corp (NYSE:MCC), FXCM Inc (NYSE:FXCM), Interactive Brokers Group, Inc. (NASDAQ:IBKR), and BGC Partners, Inc. (NASDAQ:BGCP). All of these stocks are in the investment brokerage – national industry and their market caps are similar to PJC’s market cap.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!